Acquisition Growth A&E Medical has a history of strategic acquisitions, such as acquiring Medical Concepts Europe and the Cardiothoracic Closure business from RTI Surgical. These acquisitions have expanded their product portfolio, increased their presence in Europe, and strengthened their position in the cardiovascular end markets, presenting sales opportunities for cross-selling and upselling.

Innovative Product Portfolio With a focus on physician preference products for Cardio Thoracic surgery, A&E Medical offers innovative solutions like the Thorecon™ Rigid Fixation System. This diverse and advanced product portfolio provides sales professionals with opportunities to cater to the unique needs of Cardio Thoracic surgeons and differentiate from competitors.

Strategic Partnership with Zimmer Biomet The acquisition of A&E Medical by Zimmer Biomet for $250 million indicates a strong market position and high value proposition. Sales teams can leverage this partnership to offer a comprehensive range of sternal closure devices, sternal sutures, cable systems, and rigid fixation products to healthcare institutions and cardiovascular surgery centers.

FDA Clearance for Thorecon™ System A&E Medical's Thorecon™ Rigid Fixation System received FDA 510(k) clearance. This milestone allows sales representatives to market this product as an FDA-approved solution, potentially attracting more customers seeking compliance and quality assurance in their medical equipment purchases.

Organic and Inorganic Growth A&E Medical experiences organic growth while actively acquiring complementary products and businesses. This dual approach indicates a continuous expansion of their market reach and capabilities. Sales teams can capitalize on this growth trajectory by offering a comprehensive suite of products that cater to evolving customer needs.